TITLE

Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts

AUTHOR(S)
Mi, Y; Adochi, Y; Yamomoto, H; Imsumran, A; Arimura, Y; Endo, T; Hinoda, Y; Lee, C. T; Nadaf, S; Carbone, D P; Imai, K
PUB. DATE
May 2005
SOURCE
Gut;May2005, Vol. 54 Issue 5, p591
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Insulin-like growth factor (IGF) I receptor (IGF-Ir) signalling is required for carcinogenicity and proliferation of many tumours but this pathway has not been studied in detail in gastric cancer. We have previously shown successful therapy for colorectal, pancreatic, and lung cancer using recombinant adenoviruses expressing dominant negative (dn) IGF-Ir. In this study, we sought to better dissect the role of IGF-Ir on progression of gastric cancer and determine whether IGF-Ir targeted adenoviruses represent potentially effective therapeutics for human gastric cancer. Methods: We assessed the effect of IGF-Ir ligancis on proliferation and survival in gastric cancer cells in culture. Then, recombinant adenoviruses expressing truncated IGF-Ir (482 and 950 amino acids long, IGF-Ir/dn) that function as dn inhibitors were studied in the treatment of human gastric cancer xenografts. We characterised the effects of IGF-Ir/dn on signalling blockade, growth, apoptosis induction, and in vivo therapeutic efficacy. Results: IGF-Ir signalling promoted tumour growth and survival in gastric cancer. IGF-Ir/dn expression suppressed tumorigenicity both in vitro and in vivo and upregulated stressor induced apoptosis. IGF-lr/dn blocked Akt-I activation induced by IGF-I, IGF-II, and des(1-3)IGF-I, but not by insulin. IGF-Ir/dn expression increased radiation and chemotherapy induced apoptosis and the combination of IGF-Ir/dn and chemotherapy was very effective against tumours in mice. In an intraperitoneal model, IGF-lr/dn therapy also suppressed peritoneal dissemination. Conclusions: IGF-Ir is involved in the regulation of survival and cell growth in human gastric cancer and may be a good molecular therapeutic target. Adenovirus-IGF-Ir/dn may thus have therapeutic use in gastric cancer.
ACCESSION #
16886328

 

Related Articles

  • 140. Enhanced Cell Killing Effect of E1 Modified Adenoviruses Expressing HSV-TK Suicide Gene. Oh-Joon Kwon; Dong Hyun Ko; Jing Hwa Huang; Il-Kyu Choi; Sung-Mi Jung; Joo-Hang Kim; Byoung Chul Cho; Chae-Ok Yun // Molecular Therapy;Jun2006, Vol. 13, pS56 

    To combine the advantages of the prodrug/suicide gene approach with that of replicating adenoviruses, we have developed replicating adenoviral vectors harboring HSV-TK, generating Ad-ΔE1B19-TK, Ad-ΔE1B55-TK, Ad-ΔE1B19/55-TK adenoviruses. Infection with adenoviruses expressing HSV-TK...

  • Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Galanis, E.; Okuno, S. H.; Nascimento, A. G.; Lewis, B. D.; Lee, R. A.; Oliveira, A. M.; Sloan, J. A.; Atherton, P.; Edmonson, J. H.; Erlichman, C.; Randlev, B.; Wang, Q.; Freeman, S.; Rubin, J. // Gene Therapy;Mar2005, Vol. 12 Issue 5, p437 

    ONYX-015 is a provisionally replication competent adenovirus with oncolytic activity in cells with malfunctioning p53. Sarcomas represent a rational target for this approach given the high frequency of p53 mutations (40-75%) and MDM-2 amplification (10-30%). We, therefore, undertook a phase I/II...

  • Effect of type 1 insulin-like growth factor receptor targeted therapy on chemotherapy in human cancer and the mechanisms involved. Hopkins, Alyse; Crowe, Philip J.; Jia-Lin Yang // Journal of Cancer Research & Clinical Oncology;May2010, Vol. 136 Issue 5, p639 

    Chemotherapy is administered only to patients with advanced cancers, typically to modest avail. Hence, the search for innovative approaches to treat cancer is growing rapidly. One such approach involves targeting molecular pathways identified as encouraging tumor growth and maintenance,...

  • Senesco Announces Highly Statistically Significant Tumor Growth Inhibition by a Combination of Lenalidomide and SNS01-T in Cancer Model.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article focuses on the results of a research conducted on tumor growth and inhibition factors. It informs that the research is being conducted by Senesco Technologies Inc. and informs that the results from the completed non-clinical study of lenalidomide in a model of multiple myeloma show...

  • Chemotherapy and oncolytic virotherapy: advanced tactics in the war against cancer. Nguyen, Andrew; Louisa Ho; Yonghong Wan // Frontiers in Oncology;Jun2014, Vol. 4, p1 

    Cancer is a traitorous archenemy that threatens our survival. Its ability to evade detection and adapt to various cancer therapies means that it is a moving target that becomes increasingly difficult to attack. Through technological advancements, we have developed sophisticated weapons to fight...

  • Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. McNally, L. R.; Rosenthal, E. L.; Zhang, W.; Buchsbaum, D. J. // Cancer Gene Therapy;Mar2009, Vol. 16 Issue 3, p246 

    Recent studies have demonstrated the efficacy of targeted therapy combined with radiotherapy in head and neck squamous cell carcinoma (HNSCC). We hypothesized that a combination treatment including a replicating adenovirus armed with tissue inhibitor of metalloproteinase-2 (TIMP-2), radiation...

  • Implant could measure tumor growth and monitor treatment.  // Advanced Materials & Processes;Apr2007, Vol. 165 Issue 4, p56 

    The article reports that an implant being developed at the Massachusetts Institute of Technology, Cambridge, Massachusetts, could help doctors monitor the growth of tumors and the progress of chemotherapy in cancer patients. The implant contains nanoparticles that can test for different...

  • Histotype-specific copy-number alterations in ovarian cancer. Ruby YunJu Huang; Geng Bo Chen; Matsumura, Noriomi; Hung-Cheng Lai; Seiichi Mori; Jingjing Li; Meng Kang Wong; Ikuo Konishi; Jean-Paul Thiery; Liang Goh // BMC Medical Genomics;2012, Vol. 5 Issue 1, p1 

    Background: Epithelial ovarian cancer is characterized by multiple genomic alterations; most are passenger alterations which do not confer tumor growth. Like many cancers, it is a heterogeneous disease and can be broadly categorized into 4 main histotypes of clear cell, endometrioid, mucinous,...

  • Role of the host stroma in cancer and its therapeutic significance. Tarin, David // Cancer & Metastasis Reviews;Dec2013, Vol. 32 Issue 3/4, p553 

    Current cancer research focuses mainly upon the cancer cells in malignant tumours and is providing a growing database about aberrations in their genetic composition. However, tumours also contain non-cancerous host tissue, referred to as the stroma, which plays an active and indispensable role...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics